Agilon Health, Inc. (AGL)
87.47
-2.03
(-2.27%)
USD |
NYSE |
Nov 20, 10:47
Agilon Health Free Cash Flow : -26.29M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -26.29M |
| June 30, 2026 | -107.60M |
| March 31, 2026 | -87.01M |
| December 31, 2025 | -148.87M |
| September 30, 2025 | -114.58M |
| June 30, 2025 | -92.11M |
| March 31, 2025 | -79.58M |
| December 31, 2024 | -99.06M |
| September 30, 2024 | -179.61M |
| June 30, 2024 | -186.19M |
| March 31, 2024 | -184.84M |
| December 31, 2023 | -187.01M |
| Date | Value |
|---|---|
| September 30, 2023 | -168.73M |
| June 30, 2023 | -150.96M |
| March 31, 2023 | -199.72M |
| December 31, 2022 | -163.47M |
| September 30, 2022 | -157.57M |
| June 30, 2022 | -180.97M |
| March 31, 2022 | -144.88M |
| December 31, 2021 | -161.58M |
| September 30, 2021 | -123.12M |
| June 30, 2021 | -103.59M |
| March 31, 2021 | -74.04M |
| December 31, 2020 | -55.55M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Astrana Health, Inc. | 99.42M |
| Starling Oncology, Inc. | 18.83M |
| Nakamoto, Inc. | -69.10M |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | -19.33M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 49.87M |
| Cash from Investing (Quarterly) | 17.82M |
| Cash from Financing (Quarterly) | -0.124M |
| Free Cash Flow Per Share (Quarterly) | 2.635 |
| Free Cash Flow to Equity (Quarterly) | 46.64M |
| Free Cash Flow to Firm (Quarterly) | 48.18M |
| Free Cash Flow Yield | -1.79% |